Clinical trial
Evaluate the Therapeutic Response by Using in Vitro Circulating Tumor Cell Expansion System
NCT04972461 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Therapeutic Response by Using in Vitro Circulating Tumor Cell Expansion System
- Lead sponsor
- Taipei Medical University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 8, 2018
- Completion date
- August 7, 2023
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
circulating tumor cells